Metabical Demand/Pricing Formulation Executive Summary:

There are three main demand strategy’s that make reasonable sense to
assess the demand for Metabical within the first five years. To get the most out of each demand scenario
the most optimal pricing structure was applied to each. Scenario 2 was chosen with the lowest pricing
structure to market to a wider audience during the launch with and affordable price. Pricing can always
been tweaked and justified if the product is successful and there is respective demand by the consumer base.
Scenario #1
The first scenario narrows down the target market by the follow process: 1st take the # of overweight
individuals in the United States (71.06 million), 2nd reduce 71.06 million by 35% which is the estimated
population trying to lose weight, 3rd reducing this by 15% which is the amount comfortable with weight
loss drugs which is 3.73 million, 4th Metabical will capture 10% in year one, 15% in year 2, 20% in year 3,
25% in year 4, and 30% in year 5. The Lowest pricing structure was chosen because the population chosen
was very general and may contain a large percentage of people who are price sensitive. I believe this is not
an effective demand function for Metabical because the audience is too broad. This model also in theory
will capture a small % of the target market in relation to the other models which makes it very difficult to
attain a positive ROI. This model will only bring in 185 million in revenue and is not acceptable to create
a 5% ROI. This is not even enough to cover the R&D and marketing costs.

Y Overweight Population Comfortable Medibical Population One Supply Two Supply Full Cycle
e In US Trying to With Will Captured (20%*24.80) (60%*49.60) (20%*74.40)
a Lose Weight Loss Capture
r Weight Drugs
(35%) (15%)
1 71,060,000 24,871,000 3,730,650 10% 373,065 1,850,402 11,102,414 5,551,207
2 71,060,000 24,871,000 3,730,650 15% 559,598 2,775,604 16,653,622 8,326,810
3 71,060,000 24,871,000 3,730,650 20% 746,130 3,700,805 22,204,829 11,102,414
4 71,060,000 24,871,000 3,730,650 25% 932,663 4,626,006 27,756,036 13,878,018
5 71,060,000 24,871,000 3,730,650 30% 1,119,195 5,551,207 33,307,234 16,653,621
Profit- 185,040,200 ROI -53% in 5 Years

Scenario #2 (Chosen Scenario)

The Second Strategy is more aggressive which takes the US population (209 million) and takes34% of it
who are people who are overweight which comes out to 71.06 million. Next 12%which is the target for
Metabical is taken out which comes out to 8.527 million. Metabical will capture 10% in year one, 15% in
year 2, 20% in year 3, 25% in year 4, and 30% in year 5. The lowest pricing structure was chosen because
this demographic may look into other methods to lose weight such as Jenny Craig. This model produces a
ROI of 5.7% which meet the requirements of upper level management on making a 5% ROI on 400million
in research and development costs. The pricing structure is the low which will lower the financial risk to
customers. This gives the product a better chance to sell its predicted volume. This studied demographic
contains individuals who are ready to take a pill to lose weight. Marketers cannot always predict how a
specific demographic will react to a product so a slightly broad approach will lead to opportunity for a huge
amount of revenue from not only the target market but other similar markets. (possibly a % of overweight
 women of other ages may buy into the product)Year US Pop
34%Overweight12%TargetMarketMetabicalCapturesCaptured One Supply(20%*
$24.80)TwoSupply(60%* $49.60)FullCycle(20%* $74.40)1 209,000,000 71,060,000 8,527,200 10%
852,720 $4,229,491 $25,376,947 $12,688,4742 209,000,000 71,060,000 8,527,200 15% 1,279,080
$6,344,237 $38,065,421 $19,032,7103 209,000,000 71,060,000 8,527,200 20% 1,705,440 $8,458,982
$50,753,894 $25,376,9474 209,000,000 71,060,000 8,527,200 25% 2,131,800 $10,573,728 $63,442,368
$31,721,1845 209,000,000 71,060,000 8,527,200 30% 2,558,160 $12,688,474 $76,130,842
$38,065,421Profit: 422,949,120

Y US Pop 34% 12% Target Medibical Population One Supply Two Supply Full Cycle
e Overweight Market Will Captured (20%*24.80) (60%*49.60) (20%*74.40)
a Capture
r
1 71,060,000 24,871,000 3,730,650 10% 373,065 1,850,402 11,102,414 5,551,207
2 71,060,000 24,871,000 3,730,650 15% 559,598 2,775,604 16,653,622 8,326,810
3 71,060,000 24,871,000 3,730,650 20% 746,130 3,700,805 22,204,829 11,102,414
4 71,060,000 24,871,000 3,730,650 25% 932,663 4,626,006 27,756,036 13,878,018
5 71,060,000 24,871,000 3,730,650 30% 1,119,195 5,551,207 33,307,234 16,653,621

ROI: 5.7% In 5 Years.(Bottom Line)The 5.7% ROI in this scenario shows steady growth for Metabical and
is consistent with the goals of management. In this pricing scenario a feasible number of potential customers
will be targeted and captured. It is important to analyze the demographics of what kind of customers are
purchasing each year and tweak the demand forecast or marketing strategy if necessary. For the initial
forecast a broad approach is taken with the goal of matching the 5% ROI on the 400million dollar research
and development costs. The forecast was built in Microsoft excel and can easily be modified if management
feels the need to tweak any of the factors.

Scenario #3
The third scenario targets Educated Females from ages 35-65 who are overweight (BMI of 25-30) which
equates to a population of 4.3 million people. In year one Metabical expects to have a capitalization of 30%,
then 35%, 40%, 45%, 50% respectively in the following 4 years. The highest tier of pricing was chosen due
to the demographic selection. Females who are 35-65 have the money to purchase weight loss products and
will fork over the money for a prescription. The prescription nature of the product justifies the high tier of
pricing as well as the coveted FDA approval. The ROI comes out to 67% which is a best cast scenario. I
believe the pricing structure and demand forecast is justified because this in many cases will be a life saving
product, and a pioneer in prescription weight loss. The problem with this scenario is that the ROI seems to
be unrealistic when management is only expecting a 5% ROI. Capturing 50% of such a specific market
over 5 years may be unreasonable and contain a fundamental flaw. Of course, the price could be lowered
but we feel that this is an appropriate price for the demographic and lowering the price will affect the brand
image of an elite product in the target market. Year Market % Capitalization One Supply(20%*74.80)Two
Supply(60%*149.6) Ful lCycle (20%*224.2)1 4,300,000 30 1,290,000 $19,298,400 $115,790,400
$57,895,2002 4,300,000 35 1,505,000 $22,514,800 $135,088,800 $67,544,4003 4,300,000 40 1,720,000
$25,731,200 $154,387,200 $77,193,6004 4,300,000 45 1,935,000 $28,947,600 $173,685,600 $86,842,8005
4,300,000 50 2,150,000 $32,164,000 $192,984,000 $96,492,000Profit: 1.26 Billion ROI: 215%
(Unrealistic)Marketing Communications Executive Summary: Metabical, a prescription weight loss pill
will be marketed to overweight women in the age group of 25-65. There are two main groups that Metabical
is targeting to- end users and doctors. The powerful message that being overweight can lead to life
threatening diseases and that Metabical can help will be the focus of the marketing message to both end
users and Doctors. Tracking and control after the launch is a key component to a successful venture for
Metabical. Target Market Metabical will be marketed to overweight women of the age from 25-65.
According to a 2007marketing survey it was determined that women 10% more women then men are
dissatisfied with their current weight, 20% more women then men visited a healthcare provider for a yearly
physical, 15% more women then men want to change their behavior to live a healthy lifestyle,30% more
women then men failed to lose weight in the past 5 years, 30% more women then men were dissatisfied
with current weight loss options on the market.

These results make it clear that women are the most likely gender to purchase Metabical. The age group
of 25-65 is justified because these women have expendable income which would allow them to purchase
an expensive prescription weight loss drug. It is important to maintain a healthy lifestyle and diet when
taking Metabical; this is important to understand in order to have successful weight loss with Metabical .
The women of these demographic are “knowledgeable about the importance of nutrition and exercise, they
are ready to make a change.” The women of this demographic are also “focused on reclaiming former
weight they are motivated and willing to alter current behavior” These psycho graphic behaviors are
consistent with the marketing message of Metabical. This age demographic is quite large but it is necessary
to target all of these potential customers in order understand who is buying into the product as the marketing
plan evolves over the next few years. We anticipate that other demographics will also purchase the product
and this is a major consideration in the ensuing years in what the final evolution of the product will be.
Marketing Communications Metabical is a unique product to market due to the fact that a message has to
be conveyed to the end user as well as health care providers who recommend and write prescriptions
(doctors). The target market as stated above is overweight women aged 25-65. It is important to reach the
market through a variety of venues to instill the importance of purchasing the prescription. A mix of Print
media, television, radio and online advertising will be exploited to reach the majority of the target market.
Print advertising will come in the form of pamphlets and other informative documents that will be placed
at medical clinics, weight loss facilities, doctors’ offices and other relevant institutions that promote weight
loss and a healthy lifestyle. They must instill a sense of urgency to the end user, that the time to act is now
and they should contact their health care provider to learn more about this new FDA approved weight loss
drug. Online Advertising is effective for targeting the specific target market of women who are searching
for weight loss supplements and are of age 25-65. The success of these campaigns can be measured by the
amount of impressions the advertisement has received as well as successful requests for more information
when an advertisement is clicked an an interaction takes place. Television and radio will be utilized weeks
before the drug is released to the public in order to create hype and a viral marketing effect. The types of
channels that the advertisements will be shown are news channels, channels relating to health and also
channels that women watch frequently in order to reach ou rtarget market. Being overweight is a serious
health concern that leads to life threatening diseases, judgment from society and an overall lower quality of
life. The marketing message to the target market must address this point. “Those extra 20 pounds could be
killing you. Being overweight leads to heart disease, high blood pressure, diabetes, and gallbladder disease.
It’s time to get healthy
–
Let Metabical guide you to a happier
, healthier you.” This is a powerful message that will speak
to these women who are serious about losing weight and is consistent with our goal to spread awareness of
the dangers of being overweight. It is also essential to make sure customers as well as doctors are aware of
the coveted FDA Approval because people will be hesitant to buy the
drug if they are unaware of FDA’s approval.
Targeting the professional and medical community requires a different approach. We will utilize print ads
in leading medical publications (journal of the American medical association) and interactive ads adjacent
to online physician resource information (PDR.net) to raise awareness about the drug and its benefits. The
marketing communication geared towards professionals willbe formulated to educate them about the safety,
research and development, and compliance.
(proper way to prescribe Metabical) The marketing message chosen is: “Atherosclerosis,
coronary artery disease, high blood pressure, diabetes, and gallbladder disease. Your overweight patients
are dying for help. Introducing Metabical
–
FDA
Approved Weight loss drug.” This message has all of the elements of a successful advertising campaign for
Metabical. Like the consumer message, this message is consistent in that it is meant to shock the doctor by
listing the actual diseases associated with weight loss. The end of the message gives credibility to the
product by announcing that the FDA approves the drug. It is essential to be equally successful in the
marketing to doctors as patients because if the Medical Community accepts the drug as an effective and
safe method of losing weight, more and more doctors will recommend it to patients and positive PR will
follow. Support Program A comprehensive support program will be implemented to enable customers to
receive the support they need during their weight loss journey. The center of the support system is the
website that will be developed and will include: Reference materials, a weight loss tracker, food diary,
nutritional and calorie calculator and a forum for personal support. Other weight loss programs have support
programs that have proven to be successful in the past, therefore it is essential to include this component
during the launch of the product. The website will include Social media functionality including a Twitter
and Facebook where customers and doctors can talk about their successes when taking Metabical. It is
important to model the program after other successful weight loss supplements to make sure no important
aspect is missed: An internal case study of Alli, the OTC weight loss supplement will be conducted by the
marketing department to gain a greater understanding of their support program. Goals for the support
program will be tracked and controlled including extracting data from doctors about how the patient found
outabout Metabical as well as the success of interaction with the website and social media initiatives.
Positioning It is important to determine Metabical’s positioning in the weight loss market in
order to carryout a sound marketing plan. Metabical is different then over the counter weight loss
supplements because it can only be obtained via prescription. This gives an image of an elite product that
is effective, FDA approved and can only be prescribed a doctor. People trust their doctors and the FDA
which gives Metabical a distinct advantage from over the counter wight loss products. Women who have
not has success in the past with over the counter weight loss supplements are ready for a prescription
strength option such as Metabical. After 5 years on the market Metabical should be considered the most
trusted, effective and #1 prescribed weight loss drug on the market. Time line Prior To Launch
1 Year Prior → Develop Advertising Campaigns and Marketing Materials
6 Months Prior → Utilize Focus groups to test effectiveness of chosen campaign

3 Months Prior → Direct Marketing to Doctors and healthcare providers

Day of Launch → Press Release, Viral Media Campaign

After Launch → Tracking and Control –

Make sure the target demographic is being reached.Every year analyze effectiveness of price, packaging,
and target market.BudgetAfter analyzing the budget it has been concluded that the money allocated is
appropriate. Themarketing budget should decline by a small percentage every year as the product gains
brandawareness and receives free PR from blogs, news mediums, and word of mouth recommendationfrom
customers and doctors.
http://digitaladblog.com/2012/11/20/harvard-business-case-metabical-solution/
http://www.slideshare.net/inuwisnumurti/metabical